110 related articles for article (PubMed ID: 24914854)
1. Structural insights into the coenzyme mediated monomer-dimer transition of the pro-apoptotic apoptosis inducing factor.
Ferreira P; Villanueva R; Martínez-Júlvez M; Herguedas B; Marcuello C; Fernandez-Silva P; Cabon L; Hermoso JA; Lostao A; Susin SA; Medina M
Biochemistry; 2014 Jul; 53(25):4204-15. PubMed ID: 24914854
[TBL] [Abstract][Full Text] [Related]
2. Key Residues Regulating the Reductase Activity of the Human Mitochondrial Apoptosis Inducing Factor.
Villanueva R; Ferreira P; Marcuello C; Usón A; Miramar MD; Peleato ML; Lostao A; Susin SA; Medina M
Biochemistry; 2015 Aug; 54(33):5175-84. PubMed ID: 26237213
[TBL] [Abstract][Full Text] [Related]
3. Redox- and Ligand Binding-Dependent Conformational Ensembles in the Human Apoptosis-Inducing Factor Regulate Its Pro-Life and Cell Death Functions.
Villanueva R; Romero-Tamayo S; Laplaza R; Martínez-Olivan J; Velázquez-Campoy A; Sancho J; Ferreira P; Medina M
Antioxid Redox Signal; 2019 Jun; 30(18):2013-2029. PubMed ID: 30450916
[No Abstract] [Full Text] [Related]
4. Key Role of the Adenylate Moiety and Integrity of the Adenylate-Binding Site for the NAD(+)/H Binding to Mitochondrial Apoptosis-Inducing Factor.
Sorrentino L; Calogero AM; Pandini V; Vanoni MA; Sevrioukova IF; Aliverti A
Biochemistry; 2015 Dec; 54(47):6996-7009. PubMed ID: 26535916
[TBL] [Abstract][Full Text] [Related]
5. W196 and the
Romero-Tamayo S; Laplaza R; Velazquez-Campoy A; Villanueva R; Medina M; Ferreira P
Oxid Med Cell Longev; 2021; 2021():6673661. PubMed ID: 33510840
[TBL] [Abstract][Full Text] [Related]
6. Structural bases of the altered catalytic properties of a pathogenic variant of apoptosis inducing factor.
Sorrentino L; Cossu F; Milani M; Aliverti A; Mastrangelo E
Biochem Biophys Res Commun; 2017 Aug; 490(3):1011-1017. PubMed ID: 28666871
[TBL] [Abstract][Full Text] [Related]
7. Redox-linked conformational dynamics in apoptosis-inducing factor.
Sevrioukova IF
J Mol Biol; 2009 Jul; 390(5):924-38. PubMed ID: 19447115
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of the mouse apoptosis-inducing factor AIF.
Maté MJ; Ortiz-Lombardía M; Boitel B; Haouz A; Tello D; Susin SA; Penninger J; Kroemer G; Alzari PM
Nat Struct Biol; 2002 Jun; 9(6):442-6. PubMed ID: 11967568
[TBL] [Abstract][Full Text] [Related]
9. The oxido-reductase activity of the apoptosis inducing factor: a promising pharmacological tool?
Ferreira P; Villanueva R; Cabon L; Susín SA; Medina M
Curr Pharm Des; 2013; 19(14):2628-36. PubMed ID: 23116400
[TBL] [Abstract][Full Text] [Related]
10. Defining NADH-Driven Allostery Regulating Apoptosis-Inducing Factor.
Brosey CA; Ho C; Long WZ; Singh S; Burnett K; Hura GL; Nix JC; Bowman GR; Ellenberger T; Tainer JA
Structure; 2016 Dec; 24(12):2067-2079. PubMed ID: 27818101
[TBL] [Abstract][Full Text] [Related]
11. CHCHD4 binding affects the active site of apoptosis inducing factor (AIF): Structural determinants for allosteric regulation.
Fagnani E; Cocomazzi P; Pellegrino S; Tedeschi G; Scalvini FG; Cossu F; Da Vela S; Aliverti A; Mastrangelo E; Milani M
Structure; 2024 May; 32(5):594-602.e4. PubMed ID: 38460521
[TBL] [Abstract][Full Text] [Related]
12. Redox reactions of the FAD-containing apoptosis-inducing factor (AIF) with quinoidal xenobiotics: a mechanistic study.
Misevičienė L; Anusevičius Z; Sarlauskas J; Sevrioukova IF; Cėnas N
Arch Biochem Biophys; 2011 Aug; 512(2):183-9. PubMed ID: 21664341
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-inducing factor: structure, function, and redox regulation.
Sevrioukova IF
Antioxid Redox Signal; 2011 Jun; 14(12):2545-79. PubMed ID: 20868295
[TBL] [Abstract][Full Text] [Related]
14. Structure/Function Relations in AIFM1 Variants Associated with Neurodegenerative Disorders.
Sevrioukova IF
J Mol Biol; 2016 Sep; 428(18):3650-65. PubMed ID: 27178839
[TBL] [Abstract][Full Text] [Related]
15.
Qiu Y; Wang H; Pan H; Guan J; Yan L; Fan M; Zhou H; Zhou X; Wu K; Jia Z; Zhuang Q; Lei Z; Li M; Ding X; Lin A; Fu Y; Zhang D; Wang Q; Yan Q
J Zhejiang Univ Sci B; 2023 Feb; 24(2):172-184. PubMed ID: 36751702
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations.
Brautigam CA; Chuang JL; Tomchick DR; Machius M; Chuang DT
J Mol Biol; 2005 Jul; 350(3):543-52. PubMed ID: 15946682
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-inducing factor (AIF) inhibits protein synthesis by interacting with the eukaryotic translation initiation factor 3 subunit p44 (eIF3g).
Kim JT; Kim KD; Song EY; Lee HG; Kim JW; Kim JW; Chae SK; Kim E; Lee MS; Yang Y; Lim JS
FEBS Lett; 2006 Nov; 580(27):6375-83. PubMed ID: 17094969
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
Lorenzo HK; Susin SA
Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
[TBL] [Abstract][Full Text] [Related]
19. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
Zhou Y; Feng X; Koh DW
Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of putidaredoxin reductase from Pseudomonas putida, the final structural component of the cytochrome P450cam monooxygenase.
Sevrioukova IF; Li H; Poulos TL
J Mol Biol; 2004 Feb; 336(4):889-902. PubMed ID: 15095867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
